Effect of pain relief and sedation. Chronic kidney disease, unspecified
Conditions
Interventions
Intervention 1: Intervention group: received propofol/fentanyl in doses of 0.5 to 1 mg per kg body weight. Intervention 2: Control group: midazolam/ketamine at doses of 30 to 50 micrograms and 0.25 to
Treatment - Drugs
Intervention group: received propofol/fentanyl in doses of 0.5 to 1 mg per kg body weight.
Control group: midazolam/ketamine at doses of 30 to 50 micrograms and 0.25 to 1 mg per kg body weight.
Sponsors
Mashhad University of Medical Sciences
Eligibility
Sex/Gender
All
Age
3 Years to 16 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria: candidate renal biopsy; aged 16.3 years Exclusion criteria: to prohibit the use of ketamine (a history of schizophrenia-surgical complications in the chip-history of problems and heart failure, glaucoma, history of lung disease such as severe asthma); of painkillers such as opioids; history of drug sensitivity; unwillingness to participate in the 5-under anesthesia in the operating room where the biopsy done.
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The degree of pain-relieving itching -level of patient comfort. Timepoint: One houe-3 hour- 6 hour after biopsy. Method of measurement: Scoring face pain assessment. | — |
Secondary
| Measure | Time frame |
|---|---|
| Itching. Timepoint: 1 hour-3 hour--6hour. Method of measurement: Face evaluation. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactYalda Ravanshad
Mashhad University of Medical Sciences
Outcome results
None listed